GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Senhwa Biosciences Inc (ROCO:6492) » Definitions » Receivables Turnover

Senhwa Biosciences (ROCO:6492) Receivables Turnover : 0.00 (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Senhwa Biosciences Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Senhwa Biosciences's Revenue for the three months ended in Mar. 2025 was NT$0.25 Mil. Senhwa Biosciences's average Accounts Receivable for the three months ended in Mar. 2025 was NT$0.00 Mil.


Senhwa Biosciences Receivables Turnover Historical Data

The historical data trend for Senhwa Biosciences's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senhwa Biosciences Receivables Turnover Chart

Senhwa Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.70 2.91 5.29 - -

Senhwa Biosciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Senhwa Biosciences's Receivables Turnover

For the Biotechnology subindustry, Senhwa Biosciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senhwa Biosciences's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Senhwa Biosciences's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Senhwa Biosciences's Receivables Turnover falls into.


;
;

Senhwa Biosciences Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Senhwa Biosciences's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

Receivables Turnover (A: Dec. 2024 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2024 ) / ((Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count )
=1 / ((0 + 0) / 1 )
=1 / 0
=N/A

Senhwa Biosciences's Receivables Turnover for the quarter that ended in Mar. 2025 is calculated as

Receivables Turnover (Q: Mar. 2025 )
=Revenue / Average Total Inventories
=Revenue (Q: Mar. 2025 ) / ((Accounts Receivable (Q: Dec. 2024 ) + Accounts Receivable (Q: Mar. 2025 )) / count )
=0.25 / ((0 + 0) / 1 )
=0.25 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Senhwa Biosciences  (ROCO:6492) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Senhwa Biosciences Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Senhwa Biosciences's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Senhwa Biosciences Business Description

Traded in Other Exchanges
N/A
Address
Peihsin Road, 10th Floor, No. 225, Section 3, Hsintien District, New Taipei, TWN, 23143
Senhwa Biosciences Inc is engaged in the development of new drugs and special pharmaceutical ingredients focusing on human efficacy. The company's product pipeline includes Pidnarulex (CX-5461), Silmitasertib (CX-4945), and Silmitasertib (for Moderate Covid-19). All of its revenue comes from Taiwan.

Senhwa Biosciences Headlines

No Headlines